Connection

Michael Hallek to Signal Transduction

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Signal Transduction.
Michael Hallek
Connection Strength
0.179
Signal Transduction
  1. New roles for B cell receptor associated kinases: when the B cell is not the target. Leukemia. 2019 03; 33(3):576-587.
    View in: PubMed
    Score: 0.058
  2. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-?B signaling. Leukemia. 2018 01; 32(1):72-82.
    View in: PubMed
    Score: 0.051
  3. Defects of beta 2-adrenergic signal transduction in chronic lymphocytic leukaemia: relationship to disease progression. Eur J Clin Invest. 1997 Feb; 27(2):121-7.
    View in: PubMed
    Score: 0.050
  4. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int J Cancer. 2018 01 15; 142(2):322-333.
    View in: PubMed
    Score: 0.013
  5. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood. 2009 Sep 24; 114(13):2589-97.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.